Clinical Trials Browser

Esophagogastric Adenocarcinoma × nintedanib × Gastrointestinal × Clear all

NCT02234596 2021-01-25

Nintedanib in Patients With Advanced Esophagogastric Cancer

Phase 2 Completed

34 enrolled 9 charts

Gastrointestinal

Esophagogastric Adenocarcinoma